GlassScriptPhysician profile
Howard Hao Zhang
NPI 1851302863
$10,952.29
in general payments reported to CMS, 2019-2025
40 companies · $3,291 in 2025
The $3,291 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2020: $717 · 2021: $1,207 · 2022: $933 · 2023: $1,400 · 2024: $2,140 · 2025: $3,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,731 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,731.23 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,144.94 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Janssen Biotech, INC. | $1,514.03 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $829.02 | 2019-2025 | Entyvio, Eohilia |
| Madrigal Pharmaceuticals | $700.72 | 2024-2025 | Rezdiffra, Resmetirom |
| Novo Nordisk INC | $562.71 | 2019-2025 | Wegovy |
| Phathom Pharmaceuticals, INC. | $404.82 | 2024 | Voquezna |
| Genzyme Corporation | $308.37 | 2023-2025 | |
| Stryker Corporation | $290.00 | 2020 | |
| Pfizer INC. | $260.69 | 2019-2025 | |
| Sentynl Therapeutics, INC. | $220.00 | 2021 | |
| Lilly USA, LLC | $202.98 | 2024-2025 | Omvoh |
| Erbe USA INC | $200.00 | 2023 | Erbe Vio3 |
| Janssen Scientific Affairs, LLC | $189.31 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $173.44 | 2019-2025 | |
| Evoke Pharma, INC. | $164.92 | 2022-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.